Clinical Trials
8 trialsNCT01758042 2026-03-06
BMT
Massachusetts General Hospital
Phase NA Completed
NCT01881334 2025-11-20
Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants
Duke University
Available
NCT04099966 2025-08-08
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
New York Medical College
Phase 2 Recruiting
NCT03333486 2025-07-04
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
Roswell Park Cancer Institute
Phase 2 Terminated
NCT02061800 2024-06-04
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Columbia University
Phase 1/2 Active not recruiting
NCT04629430 2023-01-04
HCTDiet
University of Virginia
Phase NA Completed
NCT02458937 2018-11-13
Functional Outcomes Following Hip Core Decompression in Younger Participants With Osteonecrosis
St. Jude Children's Research Hospital
Completed
NCT01049854 2018-08-21
CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
New York Medical College
Phase 2 Completed